Poster Impact of Prior Somatostatin Analog (Ssa) Use on Pfs in the Multicenter, Phase Iii Trial of Everolimus + Octreotide Lar Vs Placebo + Octreotide Lar in Patients With Advanced Neuroendocrine Tumours (Radiant-2)

Pavel, M.; Singh, N.; Passos, V.; Oberg, K.

European Journal of Cancer 47: S462-S463

2011


ISSN/ISBN: 0959-8049
DOI: 10.1016/s0959-8049(11)71882-2
Accession: 067137790

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal